in the department of microbiology, in a tertiary care hospital in Punjab. Stool specimens from diarrhea/dysentery cases in different age-groups were processed. The specimens were processed by standard microbiological techniques. The suspected colonies of Shigella were identified by standard biochemical tests and serotyping was done by group specific antisera. The susceptibility of all the isolated Shigella species to different antibiotics were done by Kirby-Bauer's disk diffusion technique as per the Clinical and Laboratory Standards Institute (CLSI) guidelines. Results: Shigella species were isolated from 30 (2.1%) of the total 1,402 stool samples received during the study period. Among these, Shigella fl exneri was the predominant species accounting for 57% of isolates, followed by S. sonnei (36%) and S. boydii (7%). Over 70% of Shigella isolates were resistant to two or more drugs including ampicillin, trimethoprim-sulfamethoxazole, and norfloxacin; and 10% Shigella isolates were resistant to chloramphenicol and ceftriaxone during the study period. No resistance was observed to cefoperazone/sulbactam, piperacillin/tazobactam, and imipenem. Conclusions: The results of the study revealed the high prevalence of shigellosis with S. fl exneri as the predominant species. The result also suggests that ampicillin, trimethoprim-sulfamethoxazole and norfloxacin should not be used empirically as the first line drugs in the treatment of shigellosis. Periodic analysis and reporting of antibiotic susceptibility is an important measure to check for antibiotic resistance and form appropriate treatment protocols.
INTRODUCTION
Shigellosis is a public health problem; especially in developing countries where about 163 million people are affected annually, among which 69% of cases occur in children less than 5 years. [1, 2] Intestinal infection with Shigella species can be managed by rehydration therapy; however, treatment with antimicrobial agents has been proven effective in reducing intensity and duration of symptoms and also in preventing lethal complications. [3] Shigella sp. were susceptible to many antimicrobials initially, but they have developed resistance to them over a period of time. Antimicrobial susceptibility patterns of Shigella sp. vary among its serogroups and also between geographical areas periodically. [4] A local knowledge of the distribution of Shigella serogroups, with their changing drug resistance patterns to guide empiric antimicrobial therapy is imperative in controlling shigellosis. Hence, the present study was conducted to find the prevalence, any seasonal variation, distribution among children and adults, and drug resistance pattern of Shigella isolates in stools. Fresh feces of patients were collected and transported immediately for culture. A battery of culture media including MacConkey agar, deoxycholate citrate agar (DCA), and selenite-F (SF) enrichment broth were used for the isolation of organisms. All media were incubated at 37°C for 24 h. MacConkey and DCA plates were examined and subcultures from SF were done on DCA.
MATERIALS AND METHODS
The nonlactose fermenting colonies were subjected to standard biochemical tests using triple sugar iron agar, mannitol motility medium, and indole production. Organisms biochemically resembling Shigella were serologically confirmed by specific antisera (Denka Seiken, Japan). The susceptibility of all the isolated Shigella to different antibiotics was determined by Kirby-Bauer's disk diffusion technique as per the Clinical and Laboratory Standards Institute (CLSI) guidelines. The antibiotics used were ampicillin (10 μg), trimethoprim-sulfamethoxazole (25 μg), chloramphenicol (30 μg), ciprofloxacin (5 μg), norfloxacin (10 μg), ofloxacin (2 μg), ceftriaxone (30 μg), cefoperazone-sulbactam (75/30 μg), piperacillin-tazobactam (100/10 μg), and imipenem (30 μg).
RESULTS
Of the 1,402 stool samples screened, Shigella strains were identified in 30 (2.1%) samples. Shigella sp. were isolated from patients with ages ranging between 0 and 70 years. Of these, 53% were from children from 0-18 years and the rest 47% were from adults. The clinical course was found to be more severe in children with superadded malnutrition and the peak being during the monsoons, which declined remarkably with change of season. Males outnumbered the females in all the age-groups. Shigella flexneri strains were identified in 17 (57%) Shigella positive cultures, while S. sonnei accounted for 11 (36%). S. boydii was isolated in two (7%) of the total number of isolates. S. flexneri has been predominant isolate during the period of the study.
The prevalence of resistance pattern of the isolated species during the study period is as shown in the 
DISCUSSION
In this study, we isolated 30 (2%), Shigella strains from diarrheal/dysenteric stools of 1,402 patients. This rate is similar to studies done in Nepal and Israel and other parts of India, but is considerably lower than rates seen in other developing countries. [5] [6] [7] [8] [9] [10] This difference could be due to underreporting of cases of shigellosis, improved public health measures, and continuing efforts by the health authorities to improve sanitation. The pattern of shigellosis indicates that S. flexneri was the most commonly isolated serogroup, followed by S. sonnei and S. boydii. This is comparable to the serogroup distribution seen in India and other developing countries. [11] [12] [13] It is well-known that S. flexneri is the predominant serogroup in most of the developing countries, while S. sonnei is the predominant species in developed countries. [14, 15] In this study, Shigella isolates showed maximum resistance to trimethoprim-sulfamethoxazole, followed by ampicillin and norfloxacin, which is similar to the resistance trends observed in other studies; [11, 16] while there was least resistance to ofloxacin, ceftriaxone, and imipenem. Ampicillin and trimethoprim-sulfamethoxazole were one of the commonly used drugs for the treatment of Shigellosis, but their indiscriminate use has resulted in development of resistant strains. [17] Initially, resistance to these two drugs were reported in certain strains of S. sonnei and S. dysenteriae in West Bengal during the 1990s, with similar resistance profile documented in isolates of S. flexneri in this region around the same time. [18, 19] Resistance to trimethoprim-sulfamethoxazole is caused by a variant dihydrofolate reductase (DHFR) enzyme encoded by a plasmid-mediated gene. [20] Resistance to fluoroquinolones among the Shigella isolates in this study was found to be high with high rates of resistance observed to norfloxacin than ciprofloxacin. A similar trend of increased fluoroquinolone resistance has been observed in India and other parts of the world, particularly in the Asian and African countries. [16, 21] Fluoroquinolones are recommended as the drug of choice for shigellosis by the World Health Organization. The emergence of fluoroquinolone resistant Shigella may be due to overuse of these drugs as they are empirically used for many infections like diarrhea and urinary tract infection. With the emergence of high resistance to fluoroquinolones, therapeutic options are limited. Third generation cephalosporins, pivmecillinam, and azithromycin are alternative drugs, which can be used for treatment of shigellosis. In our study, most of the isolates were susceptible to chloramphenicol and ceftriaxone and no resistance to cefoperazone/sulbactam, piperacillin/ tazobactam, and imipenem was seen. This was similar to study by Mamatha et al., at Manipal. [11] 
CONCLUSIONS
The study shows the occurrence of drug resistant shigellosis. Antibiotics may not be necessary for mild cases and if required should be guided by local data. The continuous surveillance of multidrug strains is very important to know the changing antibiotic susceptibility pattern, as well as the cyclical change of the serogroup from time to time as the resistance pattern also changes with the change in the serogroup. Analysis and periodic reporting is important in proper therapy of shigell osis.
